The financial success of Covid-19 vaccines for pharma companies is not as straightforward as expected. Despite initial gains for companies like Pfizer and Moderna, the long-term impact on stock prices raises questions about the profitability of vaccine development. Analysts warn that future pandemics may see similar trends, with companies prioritizing public health over financial gains.
Moderna Stock Pops as New Covid-19 Vaccine Shows Positive Results https://t.co/NtrJL7Wmxw
Modernaβs stock rallies after new improved COVID vaccine produced positive trial results https://t.co/I4lSOOL8jg
It's been four years since Covid-19 emerged. Who are the winners and losers of the vaccine race? @matthewherper brings you a company-by-company analysis. https://t.co/QBLo4JrBJo
.@matthewherper: During the pandemic, were great vaccines bad business? A company-by-company review https://t.co/I0J52Jkqx9 via @statnews
Was making #Covid vaccine good business for drug companies? In 2021 & 2022, as Pfizer & Moderna raked in billions from sales, the answer seemed to be an unequivocal yes. But with the passage of more time, it's not so clear, @matthewherper explains. π https://t.co/uEIg9KJvwe
Was making #Covid vaccine good business for drug companies? In 2021 & 2022, as Pfizer & Moderna raked in billions, the answer seemed to be an unequivocal yes. But with the passage of more time, it's not so clear, @matthewherper.bsky.social explains. π https://t.co/uEIg9KJvwe
During the pandemic, were great vaccines bad business? A company-by-company review https://t.co/brGI7XrKDF via @statnews Faced with a new pandemic, CEOs will respond as did with COVID despite the negative impact on stock price. Only Pharma can save the world in such a crisis.
There's no one like @matthewherper with the authority to write a compelling, no-nonsense, company-by-company review of whether great vaccines were bad business during the pandemic. https://t.co/5hkl04kW53 via @statnews
When my editors asked me to chart out who won and lost in the Covid vaccine race, I thought, "old news." But get this: the worse a large pharma did at Covid vaccines, the better they are doing now. That's not great if there is another pandemic. https://t.co/Hy1h9EIoWX
Youβd think developing a successful vaccine would be an unmitigated win, from a financial perspective. For many pharma companies, it hasn't necessarily been so. https://t.co/Lk1YkWBMDT